"Children's Hospital at Erlanger, one of four Comprehensive Regional Pediatric Centers in the state of Tennessee, provides the highest level of care with immediate access to state-of-the-art equipment and a staff of pediatric subspecialists"

During the past decade, T C Thompson Children's Hospital conducted 31 clinical trials. In the 10-year time frame, 31 clinical trials started and 47 clinical trials were completed, i.e. on average, 151.6% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 18 clinical trials were completed. i.e. 163.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "T C Thompson Children's Hospital" #1 sponsor was "Children's Oncology Group" with 69 trials, followed by "National Cancer Institute (NCI)" with 24 trials sponsored, "Mast Therapeutics, Inc." with 2 trials sponsored, "Ipsen" with 1 trials sponsored and "Seattle Children's Hospital" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "T C Thompson Children's Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 69 trials as a collaborator, "Children's Oncology Group" with 2 trials as a collaborator, "American Academy of Pediatrics" with 1 trials as a collaborator and "University College London Hospitals" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "T C Thompson Children's Hospital" are "Recurrent Neuroblastoma" (7 trials), "Acute Lymphoblastic Leukemia" (6 trials), "Adult Rhabdomyosarcoma" (5 trials), "B Acute Lymphoblastic Leukemia" (5 trials) and "Localized Resectable Neuroblastoma" (5 trials). Many other conditions were trialed in "T C Thompson Children's Hospital" in a lesser frequency.

Most popular intervention types in "T C Thompson Children's Hospital" are "Drug" (73 trials), "Other" (60 trials), "Biological" (36 trials), "Procedure" (35 trials) and "Radiation" (34 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (37 trials), "Cyclophosphamide" (32 trials), "Vincristine Sulfate" (26 trials), "Doxorubicin Hydrochloride" (23 trials) and "Etoposide" (22 trials). Other intervention names were less common.

The vast majority of trials in "T C Thompson Children's Hospital" are 96 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "T C Thompson Children's Hospital". undefined are not yet recruiting, 19 are recruiting, 34 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 42 completed trials in T C Thompson Children's Hospital, 1 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in T C Thompson Children's Hospital, 2 "Phase 1" clinical trials were conducted, 24 "Phase 2" clinical trials and 50 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".